Expression of Peroxisome Proferator-Activated Receptor γ (PPARγ) in Human Transitional Bladder Cancer and its Role in Inducing Cell Death
Open Access
- 1 October 1999
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 1 (4), 330-339
- https://doi.org/10.1038/sj.neo.7900050
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cellsGastroenterology, 1998
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patientsAnnals of Medicine, 1998
- Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonistsNature, 1997
- Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory DrugsJournal of Biological Chemistry, 1997
- Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2Biochemical and Biophysical Research Communications, 1996
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- Members of the fatty acid binding protein family are differentiation factors for the mammary gland.The Journal of cell biology, 1994
- 13- cis -Retinoic Acid: Inhibition of Bladder Carcinogenesis in the RatScience, 1977